OBJECTIVE Reduction of atherosclerotic cardiovascular disease (ASCVD) risk in patients
with diabetes requires proper management of lipid parameters. This study aimed to find the …

Methods: This was a descriptive cross-sectional study in 355 type 2 diabetic patients at
tertiary care hospital from 15th May, 2020 to 15th November, 2020 after taking ethical …

Dyslipidemia is elevation of serum total cholesterol (TC), triglycerides (TGs), or both, or low
high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of …

Background: the dyslipidemia and its associated risk factors and co-morbid diseases are the
focus of many studies in KSA, however the data regarding the prevalence are very little …

Background Diabetes mellitus (DM) is a disorder that is often associated with cardiovascular
events and underlying lipid abnormalities. Cardiovascular complications are common …

Dyslipidemia is a major risk factor for macro-vascular complications in patients with type 2
diabetes mellitus (T2DM). Present study explored pattern and predictors of dyslipidemia in …

Diabetic dyslipidaemia is characterized by raised triglycerides, low high-density lipoprotein,
raised apo-B, and small dense low density lipoprotein particles. Because detection and …

Background: Diabetes mellitus is a common health problem globally. Dyslipidaemia is a
major risk factor to develop cardiovascular disease in diabetics. They present study was …

Background: A large number of deaths worldwide are attributed to non-communicable
diseases (NCDs). Diabetes, an important NCD, contributes to this large mortality mainly …

Background Diabetic dyslipidemia is a complex multidimensional abnormality. However,
earlier studies did not focus on the prevalence of various patterns of dyslipidemia. We …